Bioxtract SA   Report issue

For profit Phase 1 Phase 2
Founded: Isnes Belgium (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2009
NCT00992004
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

curcuma longa (1 trial)

Drugs in Phase 1 Trials (1)

curcumin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2